Whitehawk Therapeutics (WHWK) Total Current Liabilities (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Total Current Liabilities of $11.1 million for Q1 2026, down 9.92% year-over-year from $12.3 million in Q1 2025, and down 23.85% on a QoQ basis from $14.5 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Total Current Liabilities data on file, last reported at $11.1 million in Q1 2026.
- Quarterly Total Current Liabilities fell 9.92% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (down 9.92% YoY) and the FY2025 annual result came in at $14.5 million, down 14.96% from the prior year.
- Total Current Liabilities declined to $11.1 million in Q1 2026 per WHWK's latest filing, from $14.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $26.4 million in Q4 2023 and bottomed at $8.8 million in Q2 2025.
- The 5-year median for Total Current Liabilities is $15.8 million (2024), against an average of $15.9 million.
- The widest annual swing landed in 2022, when Total Current Liabilities surged 470.45%; it then slumped 60.46% in 2025.
- Tracing WHWK's Total Current Liabilities over 5 years: stood at $18.8 million in 2022, then surged by 40.14% to $26.4 million in 2023, then sank by 35.31% to $17.1 million in 2024, then fell by 14.96% to $14.5 million in 2025, then declined by 23.85% to $11.1 million in 2026.
- Per Business Quant, the three latest WHWK Total Current Liabilities figures stand at $11.1 million (Q1 2026), $14.5 million (Q4 2025), and $9.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 11.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.06 Mn |
| Dec 31, 2025 | 14.52 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 12.27 Mn |
| Dec 31, 2024 | 17.07 Mn |
| Sep 30, 2024 | 15.81 Mn |
| Jun 30, 2024 | 22.15 Mn |
| Mar 31, 2024 | 19.88 Mn |
| Dec 31, 2023 | 26.40 Mn |
| Sep 30, 2023 | 20.52 Mn |
| Jun 30, 2023 | 13.00 Mn |
| Mar 31, 2023 | 17.75 Mn |
| Dec 31, 2022 | 18.84 Mn |
| Sep 30, 2022 | 17.89 Mn |
| Jun 30, 2022 | 12.60 Mn |
| Mar 31, 2022 | 11.51 Mn |
| Dec 31, 2021 | 15.27 Mn |
| Sep 30, 2021 | 11.57 Mn |
| Jun 30, 2021 | 2.21 Mn |
| Mar 31, 2021 | 2.13 Mn |
| Dec 31, 2020 | 30.06 Mn |
| Sep 30, 2020 | 2.51 Mn |
| Jun 30, 2020 | 3.11 Mn |
| Mar 31, 2020 | 2.65 Mn |
| Dec 31, 2019 | 3.33 Mn |
| Sep 30, 2019 | 3.60 Mn |
| Jun 30, 2019 | 3.60 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Dec 31, 2018 | 5.46 Mn |
| Sep 30, 2018 | 3.64 Mn |
| Jun 30, 2018 | 21.63 Mn |
| Mar 31, 2018 | 3.62 Mn |
| Dec 31, 2017 | 3.59 Mn |
| Sep 30, 2017 | 2.59 Mn |
| Jun 30, 2017 | 1.86 Mn |
| Mar 31, 2017 | 2.97 Mn |
| Dec 31, 2016 | 14.86 Mn |
| Sep 30, 2016 | 215,094.00 |
| Jun 30, 2016 | 220,762.00 |
| Mar 31, 2016 | 206,066.00 |
| Dec 31, 2015 | 205,010.00 |
| Sep 30, 2015 | 180,919.00 |
| Jun 30, 2015 | 178,223.00 |
| Mar 31, 2015 | 184,143.00 |
| Dec 31, 2014 | 160,304.00 |
| Sep 30, 2014 | 161,256.00 |
| Jun 30, 2014 | 141,528.00 |
| Mar 31, 2014 | 136,516.00 |
| Dec 31, 2013 | 133,025.00 |
| Sep 30, 2013 | 129,162.00 |
| Jun 30, 2013 | 126,773.00 |
| Mar 31, 2013 | 105,435.00 |
| Dec 31, 2012 | 103,648.00 |
| Sep 30, 2012 | 97,145.00 |
| Jun 30, 2012 | 95,402.00 |
| Mar 31, 2012 | 97,761.00 |
| Dec 31, 2011 | 74,801.00 |
| Sep 30, 2011 | 69,747.00 |
| Jun 30, 2011 | 68,385.00 |
| Dec 31, 2010 | 70,389.00 |